Icahn School of Medicine
BioMark Diagnostics, Icahn Mount Sinai to Develop Multiomic Lung Cancer Tests
The partners also aim to develop a test for determining lung cancer subtype and stage using circulating tumor cells and metabolomics.
Helio Heath Aims to Market Blood-Based Liver Cancer Screening Assay in Early 2021
The firm is engaged in multiple clinical validation trials and aims to raise more than $100 million to launch its Helio Liver Test in the US early next year.
Helio Health Collaboration Aims to Evaluate Liquid Biopsy Test for Liver Cancer
A new study aims to compare the detection performance of Helio Health's circulating tumor DNA assay with that of other screening modalities.
Mount Sinai-Led Consortium, Fluidigm Developing Epigenetic Coronavirus Dx
The consortium is developing a real-time PCR test for host detection assays targeting epigenetic signatures and viral RNA for early-stage monitoring of potentially infected individuals.